Role of deferiprone in chelation therapy for transfusional iron overload-Reference-Cited by-同舟云学术

Role of deferiprone in chelation therapy for transfusional iron overload

Published:2003-07-01 Issue:1 Volume:102 Page:17-24
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Hoffbrand A. Victor¹,Cohen Alan¹,Hershko Chaim¹

Affiliation:

1. From the Department of Haematology, Royal Free Hospital, London, United Kingdom; the Division of Hematology, Children's Hospital of Philadelphia, PA; and the Department of Medicine, Share Zedek Medical Centre, Jerusalem, Israel.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/102/1/17/1688435/h81303000017.pdf

Reference91 articles.

1. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet.1989;2: 27-30.

2. Borgna-Pignatti C, Carnelli V, Caruso V, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci.1998;850: 227-231.

3. World Health Organisation Hereditary Diseases Programme. Guidelines for the Control of Haemoglobin Disorders Booklet.1994; WHO/HDP/HB/GL/94.1.

4. Pippard MJ, Weatherall DJ. Oral iron chelation therapy for thalassaemia: an uncertain scene. Br J Haematol.2000;111: 2-5.

5. Balveer K, Pryor K, Wonke B. Combined oral and parenteral iron chelation in beta thalassaemia major. Med J Malaysia.2001;55: 493-497.

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan based hydrogel for iron (III) chelation in biological conditions;Carbohydrate Polymers;2025-01

2. Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach;International Journal of Hematology;2024-08-01

3. Article review: Brazilin as potential anticancer agent;Frontiers in Pharmacology;2024-03-07

4. Compare the Efficacy and Safety of Deferoxamine, Deferasirox, and Deferiprone in Patients With Sickle Cell Disease or Transfusion-Dependent Anemia: A Network Meta-Analysis of Randomized Control Trials;Cureus;2024-02-05

5. Broadening horizons: ferroptosis as a new target for traumatic brain injury;Burns & Trauma;2024-01-01